{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:01:34Z","timestamp":1781647294748,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00432-021-03648-w","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T03:41:55Z","timestamp":1619322115000},"page":"685-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-7821","authenticated-orcid":false,"given":"Xiaochang","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"key":"3648_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873","journal-title":"N Engl J Med"},{"key":"3648_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Dela Cruz CS (2020) Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41:1\u201324. https:\/\/doi.org\/10.1016\/j.ccm.2019.10.001","journal-title":"Clin Chest Med"},{"key":"3648_CR3","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/s1470-2045(18)30455-8","volume":"19","author":"F Blackhall","year":"2018","unstructured":"Blackhall F, Frese KK, Simpson K, Kilgour E, Brady G, Dive C (2018) Will liquid biopsies improve outcomes for patients with small-cell lung cancer? Lancet Oncol 19:e470\u2013e481. https:\/\/doi.org\/10.1016\/s1470-2045(18)30455-8","journal-title":"Lancet Oncol"},{"key":"3648_CR4","doi-asserted-by":"publisher","first-page":"200013","DOI":"10.1183\/20734735.0013-2020","volume":"16","author":"J Brodersen","year":"2020","unstructured":"Brodersen J, Voss T, Martiny F, Siersma V, Barratt A, Heleno B (2020) Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials. Breathe (Sheff) 16:200013. https:\/\/doi.org\/10.1183\/20734735.0013-2020","journal-title":"Breathe (Sheff)"},{"key":"3648_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1759-7714.12916","volume":"10","author":"M Cao","year":"2019","unstructured":"Cao M, Chen W (2019) Epidemiology of lung cancer in China. Thorac Cancer 10:3\u20137. https:\/\/doi.org\/10.1111\/1759-7714.12916","journal-title":"Thorac Cancer"},{"key":"3648_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1148\/rg.2018170081","volume":"38","author":"BW Carter","year":"2018","unstructured":"Carter BW, Lichtenberger JP 3rd, Benveniste MK, de Groot PM, Wu CC, Erasmus JJ, Truong MT (2018) Revisions to the TNM staging of lung cancer: rationale, significance, and clinical application. Radiographics 38:374\u2013391. https:\/\/doi.org\/10.1148\/rg.2018170081","journal-title":"Radiographics"},{"key":"3648_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y et al (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359:926\u2013930. https:\/\/doi.org\/10.1126\/science.aar3247","journal-title":"Science"},{"key":"3648_CR8","doi-asserted-by":"publisher","first-page":"e78S","DOI":"10.1378\/chest.12-2350","volume":"143","author":"FC Detterbeck","year":"2013","unstructured":"Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB (2013) Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:e78S-e92S. https:\/\/doi.org\/10.1378\/chest.12-2350","journal-title":"Chest"},{"key":"3648_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.molonc.2016.01.007","volume":"10","author":"MM Ferreira","year":"2016","unstructured":"Ferreira MM, Ramani VC, Jeffrey SS (2016) Circulating tumor cell technologies. Mol Oncol 10:374\u2013394. https:\/\/doi.org\/10.1016\/j.molonc.2016.01.007","journal-title":"Mol Oncol"},{"key":"3648_CR10","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1002\/cncr.28833","volume":"120","author":"IF Gareen","year":"2014","unstructured":"Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C (2014) Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National lung screening trial. Cancer 120:3401\u20133409. https:\/\/doi.org\/10.1002\/cncr.28833","journal-title":"Cancer"},{"key":"3648_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1164\/rccm.201505-0990OC","volume":"192","author":"MK Gould","year":"2015","unstructured":"Gould MK, Tang T, Liu IL, Lee J, Zheng C, Danforth KN, Kosco AE, Di Fiore JL, Suh DE (2015) Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med 192:1208\u20131214. https:\/\/doi.org\/10.1164\/rccm.201505-0990OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3648_CR12","doi-asserted-by":"publisher","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ, Jr., Wu YL, Paz-Ares L (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389:299\u2013311. https:\/\/doi.org\/10.1016\/s0140-6736(16)30958-8. https:\/\/www.cancer.org\/treatment\/understanding-your-diagnosis\/staging","DOI":"10.1016\/s0140-6736(16)30958-8"},{"key":"3648_CR13","unstructured":"IARC (2020) Latest global cancer data: cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020. https:\/\/www.iarc.who.int\/fr\/news-events\/latest-global-cancer-data-cancer-burden-rises-to-19-3-million-new-cases-and-10-0-million-cancer-deaths-in-2020\/"},{"key":"3648_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3978\/j.issn.2305-5839.2015.01.16","volume":"3","author":"N Karachaliou","year":"2015","unstructured":"Karachaliou N, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R (2015) Real-time liquid biopsies become a reality in cancer treatment. Ann Transl Med 3:36. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.01.16","journal-title":"Ann Transl Med"},{"key":"3648_CR15","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1158\/1078-0432.ccr-09-3358","volume":"16","author":"RL Katz","year":"2010","unstructured":"Katz RL, He W, Khanna A et al (2010) Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res 16:3976\u20133987. https:\/\/doi.org\/10.1158\/1078-0432.ccr-09-3358","journal-title":"Clin Cancer Res"},{"key":"3648_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/cncy.22278","volume":"128","author":"RL Katz","year":"2020","unstructured":"Katz RL, Zaidi TM, Pujara D, Shanbhag ND, Truong D, Patil S, Mehran RJ, El-Zein RA, Shete SS, Kuban JD (2020) Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules. Cancer Cytopathol 128:553\u2013562. https:\/\/doi.org\/10.1002\/cncy.22278","journal-title":"Cancer Cytopathol"},{"key":"3648_CR17","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1002\/cam4.2286","volume":"8","author":"Y Li","year":"2019","unstructured":"Li Y, Tian X, Gao L, Jiang X, Fu R, Zhang T, Ren T, Hu P, Wu Y, Zhao P, Yang D (2019) Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer. Cancer Med 8:3782\u20133792. https:\/\/doi.org\/10.1002\/cam4.2286","journal-title":"Cancer Med"},{"key":"3648_CR18","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1111\/1759-7714.13654","volume":"11","author":"WR Liu","year":"2020","unstructured":"Liu WR, Zhang B, Chen C et al (2020) Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer. Thorac Cancer 11:3234\u20133242. https:\/\/doi.org\/10.1111\/1759-7714.13654","journal-title":"Thorac Cancer"},{"key":"3648_CR19","unstructured":"Lung Cancer Research Group of Respiratory Society of Chinese Medical Association and Expert Group of China Lung Cancer Prevention and Control Alliance, Chinese experts consensus on the diagnosis and treatment of pulmonary nodules (2018) Chinese J Tuberculosis Respir Dis 41(10)"},{"key":"3648_CR20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJMoa1214726","volume":"369","author":"A McWilliams","year":"2013","unstructured":"McWilliams A, Tammemagi MC, Mayo JR et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369:910\u2013919. https:\/\/doi.org\/10.1056\/NEJMoa1214726","journal-title":"N Engl J Med"},{"key":"3648_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.21037\/tlcr.2017.06.04","volume":"6","author":"S Mohan","year":"2017","unstructured":"Mohan S, Chemi F, Brady G (2017) Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer. Transl Lung Cancer Res 6:454\u2013472. https:\/\/doi.org\/10.21037\/tlcr.2017.06.04","journal-title":"Transl Lung Cancer Res"},{"key":"3648_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jtho.2015.10.008","volume":"11","author":"AG Nicholson","year":"2016","unstructured":"Nicholson AG, Chansky K, Crowley J, Beyruti R, Kubota K, Turrisi A, Eberhardt WE, van Meerbeeck J, Rami-Porta R (2016) The International association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 11:300\u2013311","journal-title":"J Thorac Oncol"},{"key":"3648_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000499337","volume":"63","author":"G Poulet","year":"2019","unstructured":"Poulet G, Massias J, Taly V (2019) Liquid biopsy: general concepts. Acta Cytol 63:449\u2013455. https:\/\/doi.org\/10.1159\/000499337","journal-title":"Acta Cytol"},{"key":"3648_CR24","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1021\/acsnano.9b09119","volume":"14","author":"H Shin","year":"2020","unstructured":"Shin H, Oh S, Hong S et al (2020) Early-stage lung cancer diagnosis by deep learning-based spectroscopic analysis of circulating exosomes. ACS Nano 14:5435\u20135444. https:\/\/doi.org\/10.1021\/acsnano.9b09119","journal-title":"ACS Nano"},{"key":"3648_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1109\/tmi.2016.2629462","volume":"36","author":"C Sihong","year":"2017","unstructured":"Sihong C, Jing Q, Xing J, Baiying L, Tianfu W, Dong N, Jie-Zhi C (2017) Automatic scoring of multiple semantic attributes with multi-task feature leverage: a study on pulmonary nodules in CT images. IEEE Trans Med Imaging 36:802\u2013814. https:\/\/doi.org\/10.1109\/tmi.2016.2629462","journal-title":"IEEE Trans Med Imaging"},{"key":"3648_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A (2017) Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol 14:531\u2013548. https:\/\/doi.org\/10.1038\/nrclinonc.2017.14","journal-title":"Nat Rev Clin Oncol"},{"key":"3648_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3322\/caac.21212","volume":"64","author":"RA Smith","year":"2014","unstructured":"Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D, Wender RC, Brawley OW (2014) Cancer screening in the United States, 2014: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin 64:30\u201351. https:\/\/doi.org\/10.3322\/caac.21212","journal-title":"CA Cancer J Clin"},{"key":"3648_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/rccm.201410-1777CI","volume":"191","author":"LT Tanoue","year":"2015","unstructured":"Tanoue LT, Tanner NT, Gould MK, Silvestri GA (2015) Lung cancer screening. Am J Respir Crit Care Med 191:19\u201333. https:\/\/doi.org\/10.1164\/rccm.201410-1777CI","journal-title":"Am J Respir Crit Care Med"},{"key":"3648_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"3648_CR30","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/jto.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG et al (2015) The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10:1243\u20131260. https:\/\/doi.org\/10.1097\/jto.0000000000000630","journal-title":"J Thorac Oncol"},{"key":"3648_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/ijc.22134","volume":"120","author":"CA van Iersel","year":"2007","unstructured":"van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, Prokop M, Habbema JD, Oudkerk M, van Klaveren RJ (2007) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120:868\u2013874. https:\/\/doi.org\/10.1002\/ijc.22134","journal-title":"Int J Cancer"},{"key":"3648_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3322\/caac.21172","volume":"63","author":"R Wender","year":"2013","unstructured":"Wender R, Fontham ET, Barrera E Jr et al (2013) American cancer society lung cancer screening guidelines. CA Cancer J Clin 63:107\u2013117. https:\/\/doi.org\/10.3322\/caac.21172","journal-title":"CA Cancer J Clin"},{"key":"3648_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-40389-2_3","volume":"170","author":"GA Woodard","year":"2016","unstructured":"Woodard GA, Jones KD, Jablons DM (2016) Lung cancer staging and prognosis. Cancer Treat Res 170:47\u201375. https:\/\/doi.org\/10.1007\/978-3-319-40389-2_3","journal-title":"Cancer Treat Res"},{"key":"3648_CR34","doi-asserted-by":"publisher","first-page":"2082840","DOI":"10.1155\/2018\/2082840","volume":"2018","author":"Q Yang","year":"2018","unstructured":"Yang Q, Zhang P, Wu R, Lu K, Zhou H (2018) Identifying the best marker combination in CEA, CA125, CY211, NSE, and SCC for lung cancer screening by combining ROC curve and logistic regression analyses: is it feasible? Dis Markers 2018:2082840. https:\/\/doi.org\/10.1155\/2018\/2082840","journal-title":"Dis Markers"},{"key":"3648_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13402-019-00470-y","volume":"43","author":"M Yousefi","year":"2020","unstructured":"Yousefi M, Ghaffari P, Nosrati R, Dehghani S, Salmaninejad A, Abarghan YJ, Ghaffari SH (2020) Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cell Oncol (Dordr) 43:31\u201349. https:\/\/doi.org\/10.1007\/s13402-019-00470-y","journal-title":"Cell Oncol (Dordr)"},{"key":"3648_CR36","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.18632\/oncotarget.14022","volume":"8","author":"Z Yu","year":"2017","unstructured":"Yu Z, Zhang G, Yang M, Zhang S, Zhao B, Shen G, Chai Y (2017) Systematic review of CYFRA 21\u20131 as a prognostic indicator and its predictive correlation with clinicopathological features in non-small cell lung cancer: a meta-analysis. Oncotarget 8:4043\u20134050. https:\/\/doi.org\/10.18632\/oncotarget.14022","journal-title":"Oncotarget"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03648-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T08:03:09Z","timestamp":1645776189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03648-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3648"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03648-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-208455\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of Shandong First Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}